4 completed, 2 unknown. 5 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 3, Unknown 2 |
| Phase 1 | 1 | Completed 1 |
Follow Horus Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Dry Eye Syndromes (5) · Meibomian Gland Dysfunction (1)
baricitinib (1)
Poland (2) · Egypt (1) · France (1) · Spain (1) · United Kingdom (1)
Ewa Paw, MD (2) · Ahmed Elshafeey, Ph.D. Pharma (1) · Christophe Baudouin, Pr (1) · Hoffart Louis (1)